Ryu Gwanghui, Kim Do Hyun, Jeong Chang Yeong, Lee Sang Min, Lee Il Hwan, Kim Soo Whan, Yang Hyeon-Jong, Kim Mi-Ae, Kim Dong-Kyu
Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Otolaryngology-Head and Neck Surgery, Seoul Saint Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
J Rhinol. 2024 Nov;31(3):138-144. doi: 10.18787/jr.2024.00023. Epub 2024 Nov 30.
The medications preferred by patients for allergic rhinitis and their usage remain unclear. This study investigated treatment-seeking behaviors in patients with allergic rhinitis, including medical treatments, environmental controls, and surgical treatments.
In this study, a cross-sectional survey was conducted by internal medicine, pediatric, or otorhinolaryngology physicians at university hospitals from January 2022 to April 2022. A questionnaire was administered to patients with confirmed allergic rhinitis to collect information regarding medical treatments (prescription and over-the-counter medication use patterns, comorbid asthma, and allergen-specific immunotherapy), environmental controls (usage of air purifiers and pet avoidance), and experiences with surgical treatments.
We included 51 patients with allergic rhinitis with a mean age of 31.6±16.0 years. Among them, 47 (92.2%) and 6 (11.8%) patients had pollen allergies and asthma, respectively. Furthermore, 41 (80.4%) patients took prescribed medicines, while 39 (76.5%) patients only used the medication when experiencing symptoms. Thirty patients (58.8%) reported concurrent use of intranasal sprays and oral medications. Thirty-three patients (64.7%) reported awareness of immunotherapy, and there were no preferential differences between subcutaneous (52%) and sublingual immunotherapy (48%). Of the 36 patients (70.6%) who reported using an air purifier, 38.9% considered it helpful in preventing allergic rhinitis symptoms. Fourteen patients (27.5%) currently or previously had a companion animal, with half experiencing worsening of symptoms. Twelve patients had received surgical treatment and reported high satisfaction levels (41.6%, very satisfied; 41.6%, satisfied).
Patients with allergic rhinitis showed similar preferences for oral and spray medications. They also showed satisfaction with surgical treatments and an interest in the environmental management of allergic rhinitis.
患者治疗过敏性鼻炎时首选的药物及其使用情况尚不清楚。本研究调查了过敏性鼻炎患者的求医行为，包括药物治疗、环境控制和手术治疗。
本研究于2022年1月至2022年4月期间，由大学医院的内科、儿科或耳鼻喉科医生进行横断面调查。对确诊为过敏性鼻炎的患者进行问卷调查，以收集有关药物治疗（处方药和非处方药使用模式、合并哮喘和过敏原特异性免疫治疗）、环境控制（空气净化器的使用和避免接触宠物）以及手术治疗经历的信息。
我们纳入了51例过敏性鼻炎患者，平均年龄为31.6±16.0岁。其中，分别有47例（92.2%）和6例（11.8%）患者对花粉过敏和患有哮喘。此外，41例（80.4%）患者服用处方药，而39例（76.5%）患者仅在出现症状时使用药物。30例（58.8%）患者报告同时使用鼻喷雾剂和口服药物。33例（64.7%）患者报告了解免疫治疗，皮下免疫治疗（52%）和舌下免疫治疗（48%）之间无优先差异。在报告使用空气净化器的36例（70.6%）患者中，38.9%的患者认为其有助于预防过敏性鼻炎症状。14例（27.5%）患者目前或以前养过宠物，其中一半患者症状加重。12例患者接受过手术治疗，报告的满意度较高（41.6%，非常满意；41.6%，满意）。
过敏性鼻炎患者对口服药物和喷雾剂的偏好相似。他们对手术治疗也表示满意，并对过敏性鼻炎的环境管理感兴趣。
